Acadia Pharma (ACAD) Tops Q4 EPS by 64c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) | Delayed: 21.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.47 | 52 Week High | $42.49 | |||
| Open | $21.47 | 52 Week Low | $16.64 | |||
| Day High | $21.47 | P/E | N/A | |||
| Day Low | $21.47 | EPS | $-0.42 | |||
| Volume | 302 | |||||
